SOURCES SOUGHT
A -- Laboratory Centers for the DNA Re-sequencing and Genotyping Program
- Notice Date
- 4/25/2003
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, Contracts Operations Branch 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, MD, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- SS-HV-04-13
- Archive Date
- 6/7/2003
- Point of Contact
- Betty Nordan, Chief, WHI Program, Phone (301) 435-6672, Fax (301) 480-7390, - Theresa Koomson, Contract Specialist, Phone (301) 435-6674, Fax (301) 480-7390,
- E-Mail Address
-
bn4y@nih.gov, tk12w@nih.gov
- Description
- The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health is seeking to identify small businesses with the capability to provide high quality, high throughput DNA re-sequencing or genotyping for the DNA Re-sequencing and Genotyping (RS &G) Program. The overall objective of the program is to obtain reliable, rapid, and cost efficient DNA re-sequencing and genotyping to assist investigators actively engaged in elucidating the genetic components involved in the cause, variable outcome, and progression of heart, lung, blood, and sleep diseases and disorders. It is anticipated that the RS&G Program will comprise one to two laboratory centers for DNA re-sequencing, two to three laboratory centers for genotyping, and a Coordinating Center. This sources sought announcement seeks small businesses as laboratory centers for DNA re-sequencing, genotyping, or both. Under the RS&G Program, investigators from the NHLBI community will request use of the re-sequencing/genotyping service at no cost to the investigator. The Coordinating Center will be responsible for receiving the requests. An external panel of experts will evaluate the requests for caliber, interest, and feasibility for re-sequencing/genotyping. On a regular basis, the panel will identify to NHLBI those studies recommended to receive the services during the upcoming period. After approval by NHLBI, the laboratory centers will interact directly with the investigators to perform the requested re-sequencing or genotyping. The laboratory centers will obtain the samples, provide temporary storage as needed, re-sequence the regions of interest or genotype the samples, provide the data/results to the investigator, and provide reports to the Coordinating Center and NHLBI. The laboratory center investigators shall facilitate all aspects of the RS&G Program, specifically through the functions of the Steering Committee. At contract award the laboratory centers must be established laboratories with capability for immediate high throughput, high quality production. To meet the requirements of this sources sought announcement, current high quality as well as current high throughput must be documented in the capability statement. At contract award each re-sequencing center shall have the capacity to sequence at least 60,000 kilobases per year at a cost of no more than $25.00 per kilobase. The error rate shall be no more than 1 in 10,000 bases. At contract award each genotyping center shall have the capacity to provide customized genotyping services for human gene variation of at least 500,000 genotypes per year at a cost of no more than $1.50 per genotype. The error rate shall be no more than 1%. The initial total DNA re-sequencing effort (sum of all re-sequencing centers) is expected to sequence a minimum of 10 genomic regions per year of 10 genes in 48 chromosomes. The initial total genotyping effort (sum of all genotyping centers) is expected to be capable of customized genotyping of at least 100 genes per year with an average 10 SNPs per gene in an average of 1000 individuals. Further, when technology improves or needs change in the investigator community, the genotyping centers shall provide additional variations beyond SNPs and single-base insertions/deletions. During contract performance, the laboratory centers will be responsible for incorporating new technologies and methodologies to increase production, decrease costs, and improve quality. Requests from the investigator community to use the laboratory center services will be solicited to match the developing capacity of the laboratory centers. Thus the first emphasis will be on candidate genes. Named genes may be requested when capacity suffices, followed by requests for putative genes when full capacity is realized. The laboratory centers shall maintain the confidentiality of the data and results and shall not use the data and results for any purpose other than those expressly authorized by the contract. The laboratory centers shall not isolate genomic DNA from tissues or cells received from investigators. It is anticipated that the contracts will be cost-reimbursement, performance-based, for a period of 5 years. THIS IS NOT A REQUEST FOR PROPOSAL (RFP) AND NO RFP IS AVAILABLE AT THIS TIME. Small businesses who believe that they possess the capabilities to perform this work must submit an original and three copies of a capability statement to this office by May 23, 2003. The capability statement must include documentation showing that throughput capacity and quality meet the minimums stated above.
- Record
- SN00312314-W 20030427/030425213407 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |